Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies
• New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several i...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Lombardi, Andrea [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index - Cadiou, Solène ELSEVIER, 2020, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:120 ; year:2022 ; pages:77-82 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijid.2022.04.022 |
|---|
| Katalog-ID: |
ELV057727996 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV057727996 | ||
| 003 | DE-627 | ||
| 005 | 20230625002909.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220808s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2022.04.022 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica |
| 035 | |a (DE-627)ELV057727996 | ||
| 035 | |a (ELSEVIER)S1201-9712(22)00221-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 690 |a 610 |a 600 |q VZ |
| 084 | |a 30.00 |2 bkl | ||
| 084 | |a 44.13 |2 bkl | ||
| 100 | 1 | |a Lombardi, Andrea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies |
| 264 | 1 | |c 2022 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant. | ||
| 700 | 1 | |a Saydere, Atil |4 oth | |
| 700 | 1 | |a Ungaro, Riccardo |4 oth | |
| 700 | 1 | |a Bozzi, Giorgio |4 oth | |
| 700 | 1 | |a Viero, Giulia |4 oth | |
| 700 | 1 | |a Bandera, Alessandra |4 oth | |
| 700 | 1 | |a Gori, Andrea |4 oth | |
| 700 | 1 | |a Mondelli, Mario U. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Cadiou, Solène ELSEVIER |t Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index |d 2020 |g Amsterdam [u.a.] |w (DE-627)ELV00389553X |
| 773 | 1 | 8 | |g volume:120 |g year:2022 |g pages:77-82 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijid.2022.04.022 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 30.00 |j Naturwissenschaften allgemein: Allgemeines |q VZ |
| 936 | b | k | |a 44.13 |j Medizinische Ökologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 120 |j 2022 |h 77-82 |g 6 | ||
| author_variant |
a l al |
|---|---|
| matchkey_str |
lombardiandreasaydereatilungaroriccardob:2022----:netosvnsnainsraewtimncekonihbtrcieiatgneetrclsnbseiite |
| hierarchy_sort_str |
2022 |
| bklnumber |
30.00 44.13 |
| publishDate |
2022 |
| allfields |
10.1016/j.ijid.2022.04.022 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057727996 (ELSEVIER)S1201-9712(22)00221-1 DE-627 ger DE-627 rakwb eng 690 610 600 VZ 30.00 bkl 44.13 bkl Lombardi, Andrea verfasserin aut Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies 2022 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant. Saydere, Atil oth Ungaro, Riccardo oth Bozzi, Giorgio oth Viero, Giulia oth Bandera, Alessandra oth Gori, Andrea oth Mondelli, Mario U. oth Enthalten in Elsevier Cadiou, Solène ELSEVIER Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index 2020 Amsterdam [u.a.] (DE-627)ELV00389553X volume:120 year:2022 pages:77-82 extent:6 https://doi.org/10.1016/j.ijid.2022.04.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 120 2022 77-82 6 |
| spelling |
10.1016/j.ijid.2022.04.022 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057727996 (ELSEVIER)S1201-9712(22)00221-1 DE-627 ger DE-627 rakwb eng 690 610 600 VZ 30.00 bkl 44.13 bkl Lombardi, Andrea verfasserin aut Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies 2022 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant. Saydere, Atil oth Ungaro, Riccardo oth Bozzi, Giorgio oth Viero, Giulia oth Bandera, Alessandra oth Gori, Andrea oth Mondelli, Mario U. oth Enthalten in Elsevier Cadiou, Solène ELSEVIER Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index 2020 Amsterdam [u.a.] (DE-627)ELV00389553X volume:120 year:2022 pages:77-82 extent:6 https://doi.org/10.1016/j.ijid.2022.04.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 120 2022 77-82 6 |
| allfields_unstemmed |
10.1016/j.ijid.2022.04.022 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057727996 (ELSEVIER)S1201-9712(22)00221-1 DE-627 ger DE-627 rakwb eng 690 610 600 VZ 30.00 bkl 44.13 bkl Lombardi, Andrea verfasserin aut Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies 2022 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant. Saydere, Atil oth Ungaro, Riccardo oth Bozzi, Giorgio oth Viero, Giulia oth Bandera, Alessandra oth Gori, Andrea oth Mondelli, Mario U. oth Enthalten in Elsevier Cadiou, Solène ELSEVIER Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index 2020 Amsterdam [u.a.] (DE-627)ELV00389553X volume:120 year:2022 pages:77-82 extent:6 https://doi.org/10.1016/j.ijid.2022.04.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 120 2022 77-82 6 |
| allfieldsGer |
10.1016/j.ijid.2022.04.022 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057727996 (ELSEVIER)S1201-9712(22)00221-1 DE-627 ger DE-627 rakwb eng 690 610 600 VZ 30.00 bkl 44.13 bkl Lombardi, Andrea verfasserin aut Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies 2022 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant. Saydere, Atil oth Ungaro, Riccardo oth Bozzi, Giorgio oth Viero, Giulia oth Bandera, Alessandra oth Gori, Andrea oth Mondelli, Mario U. oth Enthalten in Elsevier Cadiou, Solène ELSEVIER Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index 2020 Amsterdam [u.a.] (DE-627)ELV00389553X volume:120 year:2022 pages:77-82 extent:6 https://doi.org/10.1016/j.ijid.2022.04.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 120 2022 77-82 6 |
| allfieldsSound |
10.1016/j.ijid.2022.04.022 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057727996 (ELSEVIER)S1201-9712(22)00221-1 DE-627 ger DE-627 rakwb eng 690 610 600 VZ 30.00 bkl 44.13 bkl Lombardi, Andrea verfasserin aut Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies 2022 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant. Saydere, Atil oth Ungaro, Riccardo oth Bozzi, Giorgio oth Viero, Giulia oth Bandera, Alessandra oth Gori, Andrea oth Mondelli, Mario U. oth Enthalten in Elsevier Cadiou, Solène ELSEVIER Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index 2020 Amsterdam [u.a.] (DE-627)ELV00389553X volume:120 year:2022 pages:77-82 extent:6 https://doi.org/10.1016/j.ijid.2022.04.022 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 120 2022 77-82 6 |
| language |
English |
| source |
Enthalten in Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index Amsterdam [u.a.] volume:120 year:2022 pages:77-82 extent:6 |
| sourceStr |
Enthalten in Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index Amsterdam [u.a.] volume:120 year:2022 pages:77-82 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Naturwissenschaften allgemein: Allgemeines Medizinische Ökologie |
| institution |
findex.gbv.de |
| dewey-raw |
690 |
| isfreeaccess_bool |
false |
| container_title |
Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index |
| authorswithroles_txt_mv |
Lombardi, Andrea @@aut@@ Saydere, Atil @@oth@@ Ungaro, Riccardo @@oth@@ Bozzi, Giorgio @@oth@@ Viero, Giulia @@oth@@ Bandera, Alessandra @@oth@@ Gori, Andrea @@oth@@ Mondelli, Mario U. @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00389553X |
| dewey-sort |
3690 |
| id |
ELV057727996 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV057727996</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625002909.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijid.2022.04.022</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV057727996</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1201-9712(22)00221-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="a">610</subfield><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">30.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lombardi, Andrea</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saydere, Atil</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ungaro, Riccardo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bozzi, Giorgio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Viero, Giulia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bandera, Alessandra</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gori, Andrea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mondelli, Mario U.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Cadiou, Solène ELSEVIER</subfield><subfield code="t">Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00389553X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:120</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:77-82</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijid.2022.04.022</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">30.00</subfield><subfield code="j">Naturwissenschaften allgemein: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">120</subfield><subfield code="j">2022</subfield><subfield code="h">77-82</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| author |
Lombardi, Andrea |
| spellingShingle |
Lombardi, Andrea ddc 690 bkl 30.00 bkl 44.13 Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies |
| authorStr |
Lombardi, Andrea |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00389553X |
| format |
electronic Article |
| dewey-ones |
690 - Buildings 610 - Medicine & health 600 - Technology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
690 610 600 VZ 30.00 bkl 44.13 bkl Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies |
| topic |
ddc 690 bkl 30.00 bkl 44.13 |
| topic_unstemmed |
ddc 690 bkl 30.00 bkl 44.13 |
| topic_browse |
ddc 690 bkl 30.00 bkl 44.13 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a s as r u ru g b gb g v gv a b ab a g ag m u m mu mum |
| hierarchy_parent_title |
Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index |
| hierarchy_parent_id |
ELV00389553X |
| dewey-tens |
690 - Building & construction 610 - Medicine & health 600 - Technology |
| hierarchy_top_title |
Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00389553X |
| title |
Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies |
| ctrlnum |
(DE-627)ELV057727996 (ELSEVIER)S1201-9712(22)00221-1 |
| title_full |
Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies |
| author_sort |
Lombardi, Andrea |
| journal |
Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index |
| journalStr |
Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
77 |
| author_browse |
Lombardi, Andrea |
| container_volume |
120 |
| physical |
6 |
| class |
690 610 600 VZ 30.00 bkl 44.13 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Lombardi, Andrea |
| doi_str_mv |
10.1016/j.ijid.2022.04.022 |
| dewey-full |
690 610 600 |
| title_sort |
infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor t cells, and bispecific t-cell engagers: a review of registration studies |
| title_auth |
Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies |
| abstract |
• New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant. |
| abstractGer |
• New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant. |
| abstract_unstemmed |
• New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies |
| url |
https://doi.org/10.1016/j.ijid.2022.04.022 |
| remote_bool |
true |
| author2 |
Saydere, Atil Ungaro, Riccardo Bozzi, Giorgio Viero, Giulia Bandera, Alessandra Gori, Andrea Mondelli, Mario U. |
| author2Str |
Saydere, Atil Ungaro, Riccardo Bozzi, Giorgio Viero, Giulia Bandera, Alessandra Gori, Andrea Mondelli, Mario U. |
| ppnlink |
ELV00389553X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ijid.2022.04.022 |
| up_date |
2024-07-06T16:59:17.222Z |
| _version_ |
1803849729022361600 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV057727996</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625002909.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijid.2022.04.022</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV057727996</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1201-9712(22)00221-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="a">610</subfield><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">30.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lombardi, Andrea</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• New immunological treatments have changed the management of several cancers. • The impact of these treatments on the infection risk has not been ascertained yet. • Studies and trials on immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers report several infections. • Respiratory tract, urinary tract, and device-related infections are dominant.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saydere, Atil</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ungaro, Riccardo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bozzi, Giorgio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Viero, Giulia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bandera, Alessandra</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gori, Andrea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mondelli, Mario U.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Cadiou, Solène ELSEVIER</subfield><subfield code="t">Using methylome data to inform exposome-health association studies: An application to the identification of environmental drivers of child body mass index</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00389553X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:120</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:77-82</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijid.2022.04.022</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">30.00</subfield><subfield code="j">Naturwissenschaften allgemein: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">120</subfield><subfield code="j">2022</subfield><subfield code="h">77-82</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| score |
7.398798 |